Inactive Instrument
Entasis Therapeutics Holdings Inc. Share Price
Stocks
ETTX
US2936141033
Biotechnology & Medical Research
| 1 day | -0.45% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pavel Raifeld
PSD | President | 42 | 10/07/2022 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 65 | 03/11/2019 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/04/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Heather Behanna
BRD | Director/Board Member | 51 | 31/07/2017 |
David Hastings
BRD | Director/Board Member | 64 | 31/03/2018 |
Heather Preston
BRD | Director/Board Member | 60 | 31/07/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/07/22 | Issuer sale | Chief Financial Officer | 153,900 | 0.3216% | ||
| 11/07/22 | Issuer sale | Executive/Senior Manager | 225,000 | 0.4702% | ||
| 08/07/22 | Buy | Company | 19,270,476 | 40.2712% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -.--% | - | - | 105M | ||
| -2.49% | -3.76% | +50.31% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.56B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 54.19B | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 44.66B | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 40.51B | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 36.27B | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 34.89B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.26B | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 31.01B | ||
| Average | -1.28% | -1.22% | +33.67% | +175.26% | 44B | |
| Weighted average by Cap. | -1.48% | -1.85% | +32.16% | +150.90% |
Employees
51
















